Proteome profiling outperforms transcriptome profiling for coexpression based gene function prediction by Townsend, R. Reid & et al.,
Washington University School of Medicine
Digital Commons@Becker
Open Access Publications
2017
Proteome profiling outperforms transcriptome
profiling for coexpression based gene function
prediction
R. Reid Townsend
Washington University School of Medicine in St. Louis
et al.
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Townsend, R. Reid and et al., ,"Proteome profiling outperforms transcriptome profiling for coexpression based gene function
prediction." Molecular & Cellular Proteomics.16,1. 121-134. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/5854
Proteome Profiling Outperforms Transcriptome
Profiling for Coexpression Based Gene
Function Prediction*□S
Jing Wang‡§¶, Zihao Ma‡, Steven A. Carr, Philipp Mertins, Hui Zhang**,
Zhen Zhang**, Daniel W. Chan**, Matthew J. C. Ellis§‡‡, R. Reid Townsend§§,
Richard D. Smith¶¶, Jason E. McDermott¶¶, Xian Chen, Amanda G. Paulovicha,
Emily S. Bojab, Mehdi Mesrib, Christopher R. Kinsingerb, Henry Rodriguezb,
Karin D. Rodland¶¶, Daniel C. Lieblercd, and Bing Zhang‡§¶e
Coexpression of mRNAs under multiple conditions is
commonly used to infer cofunctionality of their gene prod-
ucts despite well-known limitations of this “guilt-by-asso-
ciation” (GBA) approach. Recent advancements in mass
spectrometry-based proteomic technologies have enabled
global expression profiling at the protein level; however,
whether proteome profiling data can outperform transcrip-
tome profiling data for coexpression based gene function
prediction has not been systematically investigated. Here,
we address this question by constructing and analyzing
mRNA and protein coexpression networks for three cancer
types with matched mRNA and protein profiling data from
The Cancer Genome Atlas (TCGA) and the Clinical Pro-
teomic Tumor Analysis Consortium (CPTAC). Our analyses
revealed a marked difference in wiring between the mRNA
and protein coexpression networks. Whereas protein coex-
pression was driven primarily by functional similarity be-
tween coexpressed genes, mRNA coexpression was driven
by both cofunction and chromosomal colocalization of the
genes. Functionally coherent mRNA modules were more
likely to have their edges preserved in corresponding pro-
tein networks than functionally incoherent mRNA modules.
Proteomic data strengthened the link between gene ex-
pression and function for at least 75% of Gene Ontology
(GO) biological processes and 90% of KEGG pathways. A
web application Gene2Net (http://cptac.gene2net.org) de-
veloped based on the three protein coexpression networks
revealed novel gene-function relationships, such as linking
ERBB2 (HER2) to lipid biosynthetic process in breast can-
cer, identifying PLG as a new gene involved in complement
activation, and identifying AEBP1 as a new epithelial-mes-
enchymal transition (EMT) marker. Our results demonstrate
that proteome profiling outperforms transcriptome profiling
for coexpression based gene function prediction. Proteom-
ics should be integrated if not preferred in gene function
and human disease studies. Molecular & Cellular Pro-
teomics 16: 10.1074/mcp.M116.060301, 121–134, 2017.
Cellular functions require coordinated expression of genes
involved in the same biological pathways or protein com-
plexes. High-throughput mRNA profiling has been the domi-
nant approach to studying gene expression and its relationship
to cellular functions. Coexpression of mRNAs under multiple
conditions is commonly used to infer cofunctionality of their
gene products (1), and this “guilt-by-association” (GBA)1 heu-
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ristic is the basis for analyzing mRNA profiling data using gene
clustering (2), coexpression network analysis (3–5), and path-
way and gene set enrichment analysis (6–8). However, genes
with similar mRNA expression profiles are not necessarily
functionally coupled due to reasons such as transcriptional
leakage and nonspecific occurrence of cis-regulatory ele-
ments in the genome (9–11). Distinguishing accidental tran-
scriptional covariation from those that are functionally impor-
tant is a well-known challenge, and strategies such as meta-
analysis (12) and evolutionary constraint (10, 13) have been
developed to address this challenge.
Recent advancements in mass spectrometry-based pro-
teomic technologies have enabled global expression profiling
at the protein level, and the concordance between mRNA and
protein profiling data has been extensively studied during the
past decade (14, 15). Although a few publications suggest
that gene expression is mostly controlled at the mRNA level
(16–18), many studies have reported a considerable discrep-
ancy between mRNA and protein profiles in human and other
model organisms (15, 19–22). It is not completely clear how
much of the reported mRNA-protein discrepancy is due to
technological issues and how much is due to underlying bi-
ology. Importantly, whether proteome profiling data can out-
perform transcriptome profiling data for coexpression based
gene function prediction is largely unknown.
The deep proteome profiling data sets recently generated
by the Clinical Proteomic Tumor Analysis Consortium
(CPTAC) on the breast (23), colorectal (22), and ovarian (24)
tumors that had been transcriptomically profiled by The Can-
cer Genome Atlas (TCGA) (25–27) provided a new opportunity
to address this question. We constructed gene coexpression
networks based on mRNA and protein profiling data sets,
respectively, for each of the three cancer types. Comprehen-
sive comparisons between the mRNA and protein coexpres-
sion networks constructed for the same cancer type allowed
us to systematically investigate the relative utility of mRNA
and protein profiling data in predicting gene cofunctionality.
MATERIALS AND METHODS
Protein and mRNA Profiling Data—
Breast Cancer—The gene-level proteomics data for breast cancer
was downloaded from Mertins et al. (23). An isobaric peptide labeling
approach (iTRAQ) was employed to quantify protein levels. Protein
quantification was based on iTRAQ reporter ion ratios to the internal
standard. Data normalization was performed using a 2-component
Gaussian mixture model-based normalization algorithm. The data set
contained 9988 genes and 77 samples. Only the 6281 genes without
any missing values across all samples were included in this study. The
gene-level RNA-Seq data was downloaded from the Firehose website
(http://gdac.broadinstitute.org), which was from the Illumina HiSeq
2000 RNA Sequencing Version 2 analysis and was normalized by the
RSEM algorithm (28). The RNA-Seq data set included 20501 genes and
1058 samples. The two data sets had 5988 overlapping genes and 77
overlapping samples. Only overlapping samples and genes were in-
cluded in this study, and this was also true for the other two cancer
types.
Colorectal Cancer—The gene-level proteomics data for colorectal
cancer was downloaded from Zhang et al. (22). Label-free shotgun
proteomics was used to quantify protein levels. Protein quantification
was based on spectral counts, which were quantile normalized fol-
lowed by log-transformation. The data set contained 3899 genes and
90 samples. The gene level RNASeq data normalized by the RSEM
algorithm was downloaded from the Firehose website (http://
gdac.broadinstitute.org), which contained 20501 genes and 264 sam-
ples. There were 3764 overlapping genes and 87 overlapping samples
between the two data sets.
Ovarian Cancer—The gene-level proteomics data for ovarian can-
cer was downloaded from Zhang et al. (24). Similar to the breast
cancer data set, protein quantification was based on iTRAQ reporter
ion ratios to the internal standard. Data normalization was performed
using a global median centering algorithm. The data set contained
4186 genes across all 174 samples. Only the 3327 genes with low
technical variance and without any missing values across all samples
were included in this study. The gene-level microarray data was
downloaded from the Firehose website (http://gdac.broadinstitute.
org), which was from the Agilent 244K platform and was normalized
by the lowess normalization method (29). The microarray data set
contained 17814 genes and 541 samples. The two data sets had 2988
overlapping genes and 174 overlapping samples.
Identification of Functionally Similar and Dissimilar Gene Pairs—
Gene Ontology (GO) based semantic similarity was computed for all
gene pairs to identify functionally similar and dissimilar gene pairs.
GO—The GO vocabulary and annotation data were downloaded
from the GO website (www.geneontology.org) in November 2014. To
ensure high quality of the annotations, we excluded those denoted as
IEA (Inferred from Electronic Annotation) or ND (No biological Data
available) (30).
Calculation of Similarity Scores for Pairs of GO Terms—The Resnik
similarity score (31) was computed to measure the similarity between
each pair of GO terms. Specifically, the information content of a term
c was defined as IC(c)  -log(p(c)), where p(c) is the number of genes
annotated to the term and its descendants divided by the number of
all genes annotated to the corresponding root term (i.e. biological
process, cellular component, or molecular function). Let P(m,n) rep-
resents the set of common ancestor terms of terms m and n, the
Resnik similarity score between m and n was calculated as:
Simresnikm, nmaxcPm, nICc
Calculation of Similarity Scores for Pairs of Genes—The similarity
scores for term pairs describing two genes were combined to calcu-
late the semantic similarity score of the two genes based on the
best-match average (BMA) approach (32). Let A1 and A2 be the sets
of annotation terms for genes G1 and G2, respectively, and #G1 and
#G2 be the numbers of terms included in A1 and A2, respectively. The
BMA score for the two genes was defined as
BMAG1, G2
SG1, G2 SG2, G1
#G1 #G2
where SG1, G2  mA1 maxnA2simm, n and S(G2, G1) 
mA2 maxnA1simm, n.
All gene pairs were ranked from the highest BMA score to the lowest
BMA score. The top 1%, 5%, 10%, 15%, 20% and 25% gene pairs in
the ranked list were selected as candidate gold standard sets of func-
tionally similar gene pairs whereas the bottom 1%, 5%, 10%, 15%,
20% and 25% were selected as candidate gold standard sets of func-
tionally dissimilar gene pairs.
Comparison of Different Methods for Coexpression Network Con-
struction Using mRNA Profiling Data Sets—To select a superior meth-
odology for coexpression network construction, we compared three
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methods that are widely used for mRNA coexpression network con-
struction, including: the value-based method (33), the K-nearest
neighbor method (34), and the ARACNE (Algorithm for the Recon-
struction of Accurate Cellular Networks) method (35). The mRNA
profiling data sets for the three cancer types after overlapping with
corresponding proteomics data sets as described above were used
for method comparison. We only included positive correlations in our
analysis because we found that a strong negative correlation between
two genes did not necessarily correspond to high functional similarity
between the genes (supplemental Fig. S1), which is consistent with
previous reports (36, 37).
Method Description—In the value-based method (33), spearman’s
correlation coefficients for all pairs of genes in a data set are calcu-
lated, then a correlation threshold T is selected, and gene pairs with
correlation coefficients higher than T are connected to construct a
coexpression network. In the K-nearest neighbor method (34), after
pair-wise spearman’s correlation coefficient calculation, for each gene,
all other genes are ranked based on their correlation coefficients with
the gene, and then a coexpression network is constructed by connect-
ing the Kmutual nearest neighbors. The ARACNEmethod (5) calculates
the mutual information (MI) for all gene pairs and then estimates the
significant levels for MIs. After filtering out gene pairs with insignificant
MIs, the method examines each gene triplet among the significant gene
pairs and removes one edge based on the following criterion:
MIGi, GjminMIGi, Gk, MIGk, Gj 1 
If the tolerance  is 0, the gene pair with the smallest MI will be
removed from the gene triplet. If the tolerance  is 1, all gene pairs in the
gene triplet will be kept. Following Margolin et al. (35), the tolerance 
value was set between 0 and 0.15 to provide a reasonable tradeoff
between sensitivity and specificity.
Construction of a Consensus Coexpression Network—To increase
robustness against errors in data, a bootstrapping procedure (5) was
included in all network construction methods to generate consensus
coexpression networks. Specifically, tumor samples were randomly
sampled from the original data set with replacement and assembled
into a new bootstrapped data set containing the same number of
samples as the original data set. For each data set, we repeated this
process 100 times and generated 100 bootstrapped data sets. Next,
each of the three network construction methods was used to gener-
ate 100 bootstrapped coexpression networks based on 100 boot-
strapped data sets. The edges from the 100 bootstrapped coexpres-
sion networks were then combined to calculate a support score for
each gene pair based on the following formula:
Si  1 gene pair  Network i0 gene pair  Network i Support scorei1100Si
Then, the statistical significance of each gene pair was calculated
based on the following formulas suggested in (5):
z
support scoremu
sigma
mui1100 #Edgei#Total Edge
sigma 2i1100 #Edgei#Total Edge 1 #Edgei#Total Edge
where #Edge[i] represents the number of edges for the bootstrap
network i and #TotalEdge represents the number of unique edges
among all 100 bootstrap networks. Z score was then transformed to
the p value by comparing with the standard normal distribution. Two
genes with a p value less than 1  10	6 were then connected by an
edge to construct a consensus coexpression network.
Quantification of the Functional Relevance of a Coexpression
Network—We used likelihood ratio (LR) to quantify the functional
relevance of a coexpression network based on the sets of gold
standard functionally similar and dissimilar gene pairs described
above. Specifically,
LR
PSN/PDN
PS/PD
where P(SN) and P(DN) denote the frequencies of functionally similar
(S) and dissimilar (D) gene pairs, respectively, in the coexpression
network (N), whereas P(S) and P(D) denote all functionally similar and
dissimilar gene pairs, respectively, in our gold standard sets.
Selection of Parameters for the Three Methods—To construct a
coexpression network from a gene expression matrix, we need to set
parameters T, K, and  for the value-based method, K-nearest neigh-
bor method and ARACNE method, respectively. We tested different
values of the parameters T (from 0.40 to 0.80, step by 0.05), K (from
0.1%D to 1%D, step by 0.1%D, D is the number of genes in the
data set) and  (0, 5%, 10%, and 15%). A more stringent parameter
can usually lead to higher LR of the constructed network (supplemen-
tal Fig. S2 and supplemental Table S1). Although higher LR indicates
higher functional relevance of the constructed network and is thus
preferred, stringent parameters also lead to more isolated nodes and
reduced network coverage (supplemental Fig. S3). To balance the
tradeoff between functional relevance and coverage, a series of pa-
rameters were tested for each method and the most stringent param-
eters that produced no more than 10% isolated node were selected.
Selection of the Threshold for Identifying Functionally Similar and
Dissimilar Gene Pairs—In the section “identification of functionally
similar and dissimilar gene pairs”, we selected the top and bottom
1%, 5%, 10%, 15%, 20%, and 25% of all ranked gene pairs as the
candidate functionally similar and dissimilar gene pairs. Although a
more stringent threshold (e.g. top and bottom 1%) could lead to
higher discriminant power of the gold-standard data sets, the robust-
ness of LR calculation could be compromised when the number of
gene pairs in the gold standard data sets is small. To find a stringent
threshold that can produce robust result for each of the cancer type,
we calculated the LRs of the 100 bootstrapped networks for each of
the cancer type and then computed the coefficient of variations (CVs)
of the LRs.
Comparison of the Three Network Construction Methods—For
each of the cancer type, consensus mRNA coexpression networks
were generated using the three methods with the selected parame-
ters. Based on the functionally similar and dissimilar gene pairs from
GO, we calculated the LRs of the consensus networks and selected
the method with the highest LR to construct coexpression networks.
Construction of Protein Coexpression Networks—For the proteom-
ics data set from each of the three cancer types, we first generated
100 bootstrapped data sets using the same sets of samples as those
in the 100 bootstrapped mRNA data sets (see the section “Construc-
tion of a consensus coexpression network”). Coexpression networks
for each of the 100 bootstrapped data sets were constructed using
the method and the parameter selected based on the mRNA data
sets. The protein coexpression consensus network was then con-
structed based on the method described in the section Construction
of a Consensus Coexpression Network.
Edge Level Comparison Between mRNA and Protein Coexpression
Networks—Based on the functionally similar and dissimilar gene pairs
defined above, we calculated the LRs of mRNA and protein coex-
pression networks. For each coexpression network, we generated
1000 random networks with the same number of nodes and edges
and calculated LRs of these random networks as negative controls.
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For each coexpression network, we also built a protein-protein inter-
action network for genes in the coexpression network based on
curated protein-protein interactions from the iRef database (38) to
serve as a positive control or benchmark.
To quantify the edge-level similarity between the mRNA and pro-
tein networks, we calculated the Dice coefficient scores (39).
To test the effect of sample size on LRs of the constructed net-
works, we performed down-sampling experiments. For each of the
three cancer types, we randomly selected n samples from mRNA or
protein data (n was from 10 to 70, with a step increment of 5). Then,
we generated the consensus coexpression networks based on the
selected samples and calculated LRs based on the functionally sim-
ilar and dissimilar gene pairs. This process was repeated 100 times.
Module Level Comparison Between mRNA and Protein Coex-
pression Networks—We used the NetSAM package (40) (http://
bioconductor.org/packages/release/bioc/html/NetSAM.html) to
identify hierarchical modules from the mRNA and protein coexpres-
sion networks. Then, we performed the following analyses to com-
pare mRNA and protein modules.
Comparison of the Functional Coherence Between mRNA and
Protein Modules—We first calculated the p values of enrichment for
all GO biological process terms for each module using the hypergeo-
metric test (41) and then adjusted the p values based on the Benja-
mini and Hochberg method (42). We selected the smallest adjusted p
value as the measurement of the functional coherence of the module.
Finally, we grouped the modules from each of mRNA and protein
networks in each cancer type into three groups: a significant group
(adjusted p value  0.01), a marginally significant group (0.01 
ad-
justed p value  0.15), and an insignificant group (adjusted p value 
0.15).
Evaluation of the Conservation Level of the mRNA Modules in
Corresponding Protein Networks—We first counted the overlapping
edges between mRNA and protein networks in each cancer type.
Then, we calculated the statistical enrichment of overlapping edges in
each mRNA module based on the following hypergeometric test:
p 1
i0
k	1 mi  MmN i 
 MN 
where M, N, m and k represent the number of edges in the mRNA
network, the number of all overlapping edges, the number of edges in
a module, and the number of overlapping edges in the module,
respectively. Third, the p values were adjusted based on the Benja-
mini and Hochberg method (42). Finally, the conservation level of a
mRNA module in corresponding protein network was measured by
-log10 (adjusted p value).
Comparison of the Cytogenetic Band Coherence Between mRNA
and Protein Modules—The cytogenetic band information was down-
loaded from BioMart website (http://www.ensembl.org/biomart/, En-
semble Genes 82 and Homo sapiens genes GRCh28.p3). The anal-
yses were performed the same as described for the functional
coherent analysis, replacing GO biological process terms with cyto-
genetic bands.
Visualizing the Impact of Chromosome Colocalization on mRNA
and Protein Coexpression—We first calculated the spearman’s cor-
relation between each pair of mRNAs or proteins. Then, we ordered
the mRNAs or proteins based on their chromosome location and
visualized the pair-wise correlation scores in a heat map.
Gene Function Prediction Based on the mRNA and Protein Coex-
pression Networks—We compared mRNA and protein coexpression
networks for their gene function prediction potential for a wide variety
of GO biological processes and KEGG pathways. The KEGG pathway
data set was downloaded using REST-style KEGG API (http://rest.
kegg.jp/link/hsa/pathway). Network-based gene function prediction
was performed using the well-established random walk-based net-
work propagation algorithm (43), and prediction performance was
evaluated using 5-fold cross validation and quantified on the basis of
the area under the receiver operating characteristic curve (AUROC).
Because the random walk algorithm can only be applied to connected
networks, our analyses were based on the maximum component for
each of the six coexpression networks instead of the full networks.
Thus, networks in this section refer to the maximum component of the
full networks.
Gold-standard Positive and Negative Gene Sets—For a selected
network and a selected GO biological process or KEGG pathway
term, genes annotated to the term and also included in the network
were defined as a positive gene set and other genes in the network
constituted the negative gene set for the GO or KEGG term. Only
positive gene sets with at least 20 genes and no more than 10% of the
total number of genes in the network were included in our study. For
each cancer type, only GO and KEGG terms selected by both the
mRNA and protein networks were included in the comparative anal-
ysis. According, we had 1673, 1236, and 997 GO terms and 125, 84,
and 60 KEGG terms as gold-standard for breast, colorectal, and
ovarian cancer, respectively (see supplemental Table S2).
Random Walk Analysis—The random walk analysis exploits the
global structure of a network by simulating the behavior of a random
walker on a network. Given a network with n nodes and a set of k
“seed” gene (k  0), we used the random walk with restart (RWR)
technique (43) to calculate a priority score for each gene in the
network based on the steady state probability of the random walker
staying at the gene, which is formally defined as the following
equation:
pt1 1 rWpt rp0
where the initial vector p0 of size n was constructed such that an
equal probability of 1/k was assigned to the k seed genes, while a
probability of 0 was given to all other n–k genes in the network, r is the
restart probability (we set r as 0.5 in this paper), W is the column-
normalized adjacency matrix of the network, and pt is a vector of size
nwhere the i-th element holds the probability of being at gene i at time
step t.
The final score of a gene in the network was defined by iterating the
above equation until i1
n pit1  pit fell below the predefined threshold
of 1 10	6, as previously described (43, 44). A higher score of a gene
represents a closer relationship between the gene and the seed
genes.
AUROC Calculation—Prediction performance for each selected
GO and KEGG term was evaluated using 5-fold cross validation. We
first randomly assigned genes in the gold standard positive set into
five equal sized subgroups. We kept one subgroup as the testing
group, and then combined genes from the other four subgroups as
seed genes and calculated the priority scores of all non-seed genes in
the network based on the RWR analysis. We ranked all non-seed
genes from the highest score to the lowest score and calculated the
rank ratio of each gene by dividing its rank by the number of all
non-seed genes. Based on the rank ratios of genes in the testing
group, we used the R package pROC (https://cran.r-project.org/web/
packages/pROC/index.html) to calculate an AUROC score. The
above analysis was repeated by using each of the other subgroups as
the testing group, and then the mean AUROC was calculated across
the 5 folds. A mean AUROC of 1 indicates perfect prediction perform-
ance of the network for the GO or KEGG term, whereas a mean
AUROC of 0.5 suggest that genes annotated to the GO or KEGG term
are randomly distributed in the network.
Gene2Net Analysis—We developed Gene2Net, a web-based ap-
plication that allows users to expand one or multiple genes into a
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small network and to perform GBA analysis based on the three
protein coexpression networks generated from this study. The tool
can be accessed from the CPTAC portal in http://cptac.gene2net.org.
Briefly, network expansion is based on the random walk analysis
described above. GO biological process enrichment analysis for the
resulted networks is performed based on hypergeometric test.
Gene2Net visualizes expanded networks as interactive node-link di-
agrams and corresponding enriched GO biological processes in in-
teractive directed acyclic graphs. Using clickable Venn diagrams
and sortable heat maps, users can also compare results generated
from the three cancer types. All results in Gene2Net can also be
downloaded for further analyses. A detailed user manual and a
video tutorial are available from the Gene2Net website. For the
examples presented in this article, we set the network construction
method as Network_Expansion and the number of top ranking
neighbors as 10.
RESULTS
Summary of the mRNA and Protein Profiling Data Sets—
Table I summarizes the mRNA and protein profiling data sets
used in this study. Gene-level, normalized mRNA profiling
data for all three cancer types were downloaded from the
TCGA Firehose website (http://gdac.broadinstitute.org). Data
for breast and colorectal tumors were generated by RNA-Seq
whereas those for ovarian tumors were generated by microar-
ray. Microarray data were used for ovarian cancer because
RNA-Seq data were not available for most of the samples
analyzed by proteomics. Gene-level, normalized proteomic
data for the three cancer types were described in three recent
publications (22–24). The three proteomic data sets were
generated by different institutes using different proteomic
platforms (iTRAQ for breast and ovarian cancers and label-
free for colorectal cancer) and normalized by different algo-
rithms carefully selected and justified by individual publica-
tions. Including three methodologically diverse datasets in
this study increases the generalizability of our results. For
each cancer type, only overlapping samples and overlapping
genes with both mRNA and protein abundance data were
included in our analysis. Accordingly, breast, colorectal, and
ovarian cancer analyses were based on 77 samples and 5988
genes, 87 samples and 3764 genes, and 174 samples and
2988 genes, respectively.
Comparison of Methods for Coexpression Network Con-
struction—Using the mRNA profiling data sets from the three
cancer types, we compared three methods that are widely
used for mRNA coexpression network construction, includ-
ing: the value-based method (33), the K-nearest neighbor
method (34), and the ARACNE method (35). For each method,
the most stringent parameter that produced no more than
10% isolated node in the constructed network (supplemental
Fig. S3) was used for this study. The bootstrapping procedure
(5) was included in all methods to build consensus networks
that are more robust to sampling variability and errors in the
data.
To evaluate the functional relevance of the networks con-
structed by different methods, we derived “gold-standard” by
calculating pair-wise semantic similarity for all genes based
on GO biological process, molecular function, and cellular
component annotations, respectively. For each type of GO
annotation, the top 5% of gene pairs with the highest similar-
ity scores were designated as a positive set of functionally
similar gene pairs whereas the bottom 5% were designated
as a negative set of functionally dissimilar gene pairs. The 5%
threshold was selected to maximize the discriminant power of
the gold-standard sets while ensuring the robustness of the
evaluation results (supplemental Fig. S4).
To compare the functional relevance of the networks con-
structed by the three methods, we computed the LRs of
neighboring genes being functionally similar versus dissimilar
using the gold standard sets. As shown in supplemental Fig.
S5, the K-nearest neighbor method resulted in the highest
LRs for all cancer types and all GO ontologies, except for the
combination of ovarian cancer and biological process, where
the value-based method had the highest LR. Accordingly, we
selected the K-nearest neighbor method for coexpression
network construction in this study and the optimal K was 12,
11, and 9 for breast, colorectal, and ovarian cancer, respec-
tively (supplemental Fig. S3).
mRNA and Protein Coexpression Networks are Wired Very
Differently—Based on the K-nearest neighbor method and the
optimal Ks, we construct both mRNA and protein coexpres-
sion networks for the three cancer types (supplemental Tables
S3–S9). For breast cancer (5988 genes), the mRNA coexpres-
sion network had 22,940 edges whereas the protein coex-
pression network had 19,925 edges. These numbers were
10,713 and 13,110 for colorectal cancer (3764 genes), and
7815 and 6091 for ovarian cancer (2988 genes).
As shown in Fig. 1A, there was very limited overlap in edges
between mRNA and protein coexpression networks for all
three cancer types (Dice coefficient 
 0.15, p1 for overlap-
ping significance based on the Fisher’s exact test). The over-
lap remained low (Dice coefficient 
 0.25) even when K was
increased to 599, 376, and 299 for breast, colorectal, and
ovarian cancers, respectively (i.e. up to 10% of all genes in a
network were considered as direct neighbors for each gene,
TABLE I
Summary of the mRNA and protein profiling data sets
Cancer type
mRNA Protein Matched data
Sample # Gene # Technology Data source Sample # Gene # Technology Data source Sample # Gene #
Breast 1058 20501 Illumina HiSeq 2000 Firehose 77 6281 iTRAQ Ref23 77 5988
Colorectal 264 20501 Illumina HiSeq 2000 Firehose 90 3899 label-free Ref22 87 3764
Ovarian 541 17814 Agilent 244K Firehose 174 3327 iTRAQ Ref24 174 2988
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supplemental Fig. S6). These results indicate that mRNA and
protein coexpression networks are wired very differently.
Protein Networks are More Closely Aligned with Function—
Both mRNA (blue bars) and protein (red bars) coexpression
networks were more likely to connect functionally similar gene
pairs than dissimilar gene pairs, with LRs ranging from 3 to 30
(Fig. 1B). These values were significantly higher than those
calculated for corresponding random networks with the same
numbers of nodes and edges (light blue and light red bars,
p 
 2.2e-16). Deviation of the LRs of the random networks
from 1 (log likelihood ratio  0) can be explained by the
enrichment of genes quantified by both technologies in cer-
tain GO terms.
Protein networks showed higher (1.4-fold to 4.8-fold) LRs
than corresponding mRNA networks (Fig. 1B). As depicted in
Fig. 1C, for breast and colorectal cancers, common edges
shared by both mRNA and protein coexpression networks
showed the highest LRs (magenta bars), followed closely by
edges specific to protein coexpression networks (red bars).
For ovarian cancer, edges specific to protein coexpression
networks outscored the common edges. For all three cancer
types, edges specific to mRNA coexpression networks (blue
bars) showed the lowest LRs. Notably, the LRs of the protein
coexpression networks approached those of the benchmark
networks constructed based on curated protein-protein inter-
actions from the iRef database (38) (green bars, Fig. 1B).
These data quantitatively demonstrate that protein coexpres-
sion networks are highly functionally relevant, and they are
more closely aligned with function than mRNA coexpression
networks.
To evaluate the sample size effect on the functional rele-
vance of the constructed mRNA and protein coexpression
FIG. 1. Edge level comparison between mRNA and protein coexpression networks of the three cancer types. A, Edge overlap between
mRNA coexpression network (blue) and protein coexpression network (red). B, The likelihood ratios (LRs) calculated for individual networks
with gold-standard reference data sets derived from GO biological process (BP), cellular component (CC) and molecular function (MF)
annotations, respectively. Blue, light blue, red, light red and green bars represent mRNA coexpression network, mRNA random network,
protein coexpression network, protein random network, and protein-protein interaction (PPI) network, respectively. C, The LRs of mRNA
specific edges (blue), protein specific edges (red), and common edges (magenta).
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networks, we further performed down-sampling analysis. As
shown in Fig. 2, protein networks had higher LRs than corre-
sponding mRNA networks for all the sample sizes tested,
ranging from 10 to 70. Both mRNA and protein coexpression
networks had increased LRs with larger sample sizes, but a
bigger sample size-dependent LR increase was observed
among protein coexpression networks. For all three cancer
types, the largest LR increase was found when the sample
size went from 10 to 20. Therefore, we recommend a min-
imal sample size of 20 for protein coexpression network
construction.
Protein Network Modules are More Functionally Homoge-
neous—We next studied the functional homogeneity of net-
work modules in the coexpression networks. Biological net-
works usually have a hierarchical modular organization (45)
and network modules with tightly connected components are
considered as functional blocks of the cell (46). We used the
NetSAM algorithm (40) to reveal hierarchical modular archi-
tectures of the coexpression networks and then performed
enrichment analysis to evaluate the functional coherence of
the identified modules (supplemental Tables S10–S15).
Among the 122, 61, and 55 mRNA modules identified for
breast, colorectal, and ovarian cancer, 16%, 26%, and 15%
were enriched in at least one GO biological process (multiple-
test adjusted p 
 0.01, hypergeometric test), respectively. In
contrast, among the 88, 62 and 36 protein modules for the
three cancer types, significantly larger proportions (73%,
63%, and 67%; p 
 2.2e-16, p  5.8e-05, and p  4.7e-07,
respectively, Fisher’s exact test) showed significant GO en-
richment (Fig. 3A). To examine the conservation level of the
mRNA modules in corresponding protein networks, we per-
formed the hypergeometric test for each mRNA module to
quantify the statistical enrichment of its edges in the corre-
sponding protein network. As depicted in Fig. 3B, functionally
coherent mRNA modules (i.e. red modules with significant GO
enrichment) were more likely to have their edges preserved in
corresponding protein networks than functionally incoherent
mRNA modules (i.e. blue modules with insignificant GO en-
richment), with p values equal 2.8e-08, 1.6e-04, and 0.06 for
breast, colorectal, and ovarian cancer, respectively (one-
sided Kolmogorov-Smirnov test).
To further explore other possible biological underpinnings
of the coexpression modules, we performed cytogenetic band
enrichment analysis for both mRNA and protein modules (Fig.
4A). Interestingly, 76%, 59 and 87% of the mRNA modules in
breast, colorectal, and ovarian cancers were enriched in at
least one cytogenetic band (multiple-test adjusted p 
 0.01,
hypergeometric test), and the ratios were significantly higher
FIG. 2. Sample size effect on the functional
relevance of coexpression networks. x axis
represents the numbers of samples in down-
sampling analyses and y axis represents the av-
erage values of the natural logarithm transformed
LRs for 100 coexpression networks generated by
randomly selected samples for different sample
sizes. Each error bar represents the S.D. of the
natural logarithm transformed LRs for one set of
100 coexpression networks. Red and blue lines
represent the protein and mRNA coexpression
networks, respectively.
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in functionally incoherent mRNA modules (89%, 72%, and
98%) than in functionally coherent mRNA modules (35%,
31%, and 25%, p 
 0.05, Fisher’s exact test). For all three
cancer types, significantly smaller proportions (15%, 14%,
and 50%) of the protein modules showed significant cytoge-
netic band enrichment compared with the mRNA modules
(p 
 2.2e-16, p  2.8e-07, and p  2.1e-04, respectively,
Fisher’s exact test). In breast cancer and colorectal cancer,
the proportions of the cytogenetic band enriched modules
were similar between functional coherent and incoherent pro-
tein modules (p 0.56 and 0.18, Fisher’s exact test), whereas
in ovarian cancer, this proportion was significantly lower in
functionally coherent modules than in functionally incoherent
modules (29% versus 89%, p 0.01, Fisher’s exact test). The
impact of chromosomal colocalization on mRNA coexpres-
sion is obvious for all cancer types when visualizing gene
coexpression along human chromosomes, as indicated by
the striking red diagonal lines, but such impact was much
weaker at the protein level, and the difference was highly
statistically significant for most of the chromosomes (supple-
mental Fig. S7-S9). Taken together, our results demonstrate
that protein coexpression modules are primarily driven by
functional homogeneity of the genes, whereas chromosomal
colocalization plays a significant role in determining mRNA
coexpression. Moreover, functionally coherent mRNA mod-
ules are preferably preserved in protein networks.
Protein Networks Better Predict Biological Functions—To
evaluate the relative utility of mRNA and protein profiling data
in predicting gene cofunctionality, we compared mRNA and
protein coexpression networks for their gene function predic-
tion potential for a wide variety of GO biological processes
and KEGG pathways. Network-based gene function predic-
tion was performed using the random walk-based network
propagation algorithm (43), and prediction performance was
evaluated using 5-fold cross validation and quantified on the
basis of the AUROC. GO biological process and KEGG path-
way terms were selected for each cancer type separately
(supplemental Table S2) based on the size filtering criteria
described in Materials and Methods. Protein networks
showed better prediction performance compared with corre-
sponding mRNA networks for 85%, 78 and 92% of the GO
terms for breast, colorectal, and ovarian cancer, respectively
(Fig. 5A, supplemental Table S16). Protein networks achieved
good performance (AUROC  0.8) for 223, 144, and 206 GO
terms for breast, colorectal, and ovarian cancer, respectively.
In contrast, mRNA networks achieved good performance only
for 46, 71, and 8 GO terms for the three cancer types, respec-
tively, and the vast majority of these overlapped with the GO
terms for which protein networks had good performance (Fig.
5A). In the analyses based on KEGG pathway terms, protein
networks demonstrated an even more striking advantage
compared with mRNA networks, and performance gain was
FIG. 3. Functional homogeneity of mRNA
and protein coexpression modules. A, Pie
charts comparing the functional coherence be-
tween mRNA and protein modules from the three
cancer types. Red, green and blue represent
modules with significant (adjusted p value 
0.01), marginally significant (0.01
adjusted p
value  0.15), and insignificant (adjusted p
value  0.15) GO biological process enrichment,
respectively. The total number of modules for
each network is provided under each pie chart.
The proportion differences between the same
colored sections in the mRNA and protein pie
charts are indicated in the parentheses beside
the proportional number of the protein pie chart.
The “” and “-” signs correspond to higher and
lower proportion in the protein pie chart com-
pared with corresponding mRNA pie chart, re-
spectively. The p values in the parentheses were
calculated by two-sided Fisher’s exact test. B,
Empirical cumulative distribution plots of the
conservation scores of mRNA modules in corre-
sponding protein networks for individual module
groups. Line colors represent the same module
groups as in (A). The p values were calculated by
one-sided Kolmogorov-Smirnov test.
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obvious for KEGG pathways previously reported to have poor
mRNA-protein correlations (22–24), such as oxidative phos-
phorylation and spliceosome (Fig. 5B, supplemental Table
S17). For 23 GO biological process terms and 11 KEGG
pathway terms, good performance was achieved by all three
protein networks, but by none of the mRNA networks (sup-
plemental Tables S16–S17). These processes and pathways
covered a wide range of biological phenomena including cell
cycle, tricarboxylic acid cycle, focal adhesion, mRNA surveil-
lance pathway, spliceosome, antigen processing and presen-
tation, gluconeogenesis, regulation of ligase activity, lipid
oxidation, mitotic DNA integrity checkpoint, mitochondrial
transport, among others. These results show that proteomics
data strengthened the connection between gene expression
and function for at least 75% of the GO biological processes
and 90% of the KEGG pathways. Our analyses also identified
specific biological processes and pathways whose assess-
ment would benefit most from direct protein measurements.
Protein Networks Reveal Novel Gene-function Relation-
ships—To make the highly functionally relevant breast, colo-
rectal, and ovarian cancer protein coexpression networks
available and useful to the broad scientific community, we
developed a web application Gene2Net, which allows users to
expand one or multiple genes into a small network based on
the protein coexpression networks and then perform GBA
analysis to generate hypotheses on gene-function relation-
ships. Here we use some examples to illustrate the potential
use of the tool.
First, we applied the tool to predict functions for all recently
published driver genes (47) in the three cancer types (see
FIG. 4. Impact of chromosome colocalization on mRNA and protein coexpression. A, Pie charts comparing the cytogenetic band
enrichment analysis results between mRNA and protein modules from the three cancer types. Black, dark gray and light gray colors represent
modules with significant (adjusted p value  0.01), marginally significant (0.01 
adjusted p value  0.15), and insignificant (adjusted p value
0.15) cytogenetic band enrichment, respectively. The description of the proportion differences and p values in the parentheses can be found
in the Fig. 3A legend. B, Bar charts depict results for individual module groups. The border colors of the bars and x axis labels represent the
same module groups as defined in Fig. 3A, with red, green and blue border colors representing modules with significant (adjusted p value 
0.01), marginally significant (0.01
adjusted p value  0.15), and insignificant (adjusted p value  0.15) GO biological process enrichment,
respectively. p values are calculated by the Fisher’s exact test.
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supplemental Table S18). Among the 126, 39, and 27 drivers
that were included in the breast, colorectal, and ovarian can-
cer networks, we were able to predict functions for 38, 10, and
14 genes, respectively (GO enrichment analysis under FDR
1%, See supplemental Table S19–S22). Previously known GO
annotations were identified for 27, 9, and 11 among these
genes. For example, using KRAS, a frequently mutated gene
in colorectal cancer, to query the colorectal cancer network,
we associated the gene to its well-known role in Ras protein
signaling transduction (Fig. 6A). Using CDH1 to query the
breast cancer network, we associated the gene to its well-
established role in cell adhesion (Fig. 6B). Using STAG1 to
query the ovarian cancer network, we associated the gene to
known function in cell cycle (Fig. 6C). Moreover, new GO
annotations were predicted for 21, 6, and 11 of the driver
genes in the three cancer types, respectively. Some of these
predicted annotations were closely related to existing GO
annotations for the genes, but others associated the genes
to new biological processes. For examples, using ERBB2
(HER2), a frequently amplified gene in breast cancer, to query
the breast cancer network, we associated the gene to lipid
biosynthetic process (Fig. 6D). Although ERBB2 has not been
annotated to this process by GO, ERBB2 positive breast
cancers have been shown to produce significantly high
amounts of fats and the fat synthetic process is required for
survival of ERBB2-positive breast cancer cells (48). Accord-
ingly, knock down of two lipid synthesis genes in our ERBB2
network (ACACA and FASN) has been shown to significantly
decrease cell viability of the ERBB2-positive breast cancer
cell line BT474 (48).
In addition to individual genes, gene lists can also be used
as input to Gene2Net. To identify new players in complement
activation, a central process of cancer immunity (49), we
queried each of the three networks using a list of complement
activation genes annotated by GO. The three complement
activation networks shared 15 common genes (Fig. 6E), in-
cluding a new gene PLG (plasminogen) that was not included
in GO annotation. Consistent with this prediction, a recent
FIG. 5. Gene function prediction based on mRNA and protein coexpression networks of the three cancer types. A, Scatter plots
comparing the gene function prediction performance between mRNA and protein coexpression networks of the three cancer types based on
GO biological process annotations. GO terms are represented by circles and grouped according to their combination of AUROCs from mRNA
and protein networks, as indicated by different colors. B, Scatter plots comparing the gene function prediction performance between mRNA
and protein coexpression networks of the three cancer types based on KEGG pathway annotations. KEGG pathway terms are represented by
circles and grouped according to their combination of AUROCs from mRNA and protein networks, as indicated by different colors. Two KEGG
pathways previously reported to have poor mRNA-protein correlations are indicated by arrows.
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study showed that PLG can serve as a complement inhibitor
in addition to its well-established role in fibrinolysis (50). As
another example, we queried each of the three networks
using a list of genes curated in MsigDB (6) for the epithelial-
mesenchymal transition (EMT), which plays a critical role in
promoting metastasis in epithelium-derived carcinomas (51).
The three EMT networks shared 42 common genes, including
a new gene, AEBP1 (AE binding protein 1, Fig. 6F). Interest-
ingly, AEBP1 is one of ten genes in a recently published
pan-cancer EMT signature (52).
The above examples demonstrate that our protein coex-
pression network-based tool allows retrieval of known func-
tions for a gene, prediction of new functions, and identifica-
tion of new genes for a biological process of interest.
DISCUSSION
With matched mRNA and protein profiling data from three
cancer types, we have performed the first systematic study to
investigate the relative utility of mRNA and protein profiling
data in predicting gene cofunctionality. Although many stud-
ies have reported only a moderate correlation between mRNA
and protein profiles (15, 19–22), whether protein profiling data
better reflects cellular functions has remained unanswered,
because the reported mRNA-protein discrepancy may have
both biological and technical explanations (16, 17, 21). Our
study provided quantitative evidence to demonstrate that pro-
tein profiling data is more closely aligned with function than
mRNA profiling data. Proteomic data strengthened the link
between gene expression and function for the vast majority
of biological processes and pathways. We identified a sub-
set of biological processes and pathways for which protein
measurements would be most critical. We also developed
Gene2Net, which will allow biologists to generate hypothe-
ses on new gene-function relationships based on the pro-
tein coexpression networks.
Although mRNA profiling has been the dominant approach
to studying gene expression and its relationship to cellular
functions, it has been suggested that genes with similar
mRNA expression profiles are not necessarily functionally
coupled (11). Our results showed that chromosomal colocal-
ization plays a significant role in determining mRNA coexpres-
sion. Somatic copy number alteration may be an important
driver of this phenomenon (22–24). In addition, genomic
colocalization-driven coexpression has been previously re-
ported in Caenorhabditis elegans (53) and Saccharomyces
cerevisiae (54). Thus, this observation may also be explained
by other mechanisms such as colocalization of coexpressed
genes in regions of active chromatin or enhancers shared by
neighboring genes on chromosomes. The impact of genomic
colocalization on gene coexpression is significantly reduced
FIG. 6. Protein coexpression network-based inference of gene-function relationship. A, KRAS network in colorectal cancer. The small
nodes are the top ranking neighbors of KRAS, and red nodes represent genes participating in Ras protein signaling transduction. B, CDH1
network in breast cancer, and red nodes represent genes participating in cell adhesion. C, STAG1 network in ovarian cancer, and red nodes
represent genes participating in mitotic cell cycle. D, ERBB2 network in breast cancer. The small nodes are the top ranking neighbors of
ERBB2, and red nodes represent genes participating in lipid biosynthetic process. E, Tri-cancer complement activation network. The small
nodes represent known complement activation genes annotated to the GO term (GO:0006956) and the large node represents the common top
ranking neighbor across the three cancer types. Red, blue and green lines represent edges from breast cancer, colorectal cancer, and ovarian
cancer network, respectively. F, Tri-cancer EMT network. The small nodes represent known EMT related genes and the large node represents
the common top ranking neighbor across the three cancer types.
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at the protein level than mRNA level. (supplemental Fig. S7–
S9). Although mRNA coexpression was driven by both co-
function and chromosomal colocalization of the genes, pro-
tein coexpression was driven primarily by functional similarity
between coexpressed genes. Importantly, functionally coher-
ent mRNA modules are preferably preserved in protein net-
works (Fig. 3B), suggesting a role of protein level regulation in
coordinating gene functions.
Among the three cancer types, proteomic data provided the
largest added value for ovarian cancer (Fig. 1B, Fig. 3). We
note that mRNA profiling data for ovarian cancer were gen-
erated by microarray, whereas mRNA data for breast and
colorectal cancers were generated by RNA-Seq. The ob-
served differences may be partially attributable to the different
platforms. However, this also may reflect the unique biology
of ovarian cancer. Prevalent copy number alterations in ovar-
ian cancer (27) may create widespread gene expression al-
terations at the transcriptome level, thereby requiring more
extensive post-transcriptional regulation to buffer against
non-functional alterations (11, 55). Indeed, chromosomal co-
localization had a much stronger impact on mRNA coexpres-
sion in ovarian cancer compared with the other two cancer
types, and such impact was reduced, but still visible at the
protein level in ovarian cancer (supplemental Fig. S9).
Although current proteomic platforms can identify more
than ten thousand proteins, the number of quantifiable pro-
teins remain much smaller than those can be quantified by
mRNA profiling. In this study, the quantifiable proteins in the
breast, colorectal, and ovarian data sets were 6281, 3899,
and 3327, respectively, whereas the number of quantified
genes in corresponding mRNA profiling data sets were 20501,
20501, and 17814. Our study was limited to genes with both
mRNA and protein abundance measurements. but we believe
our conclusion is not biased, because the same trend was
observed with the number of studied genes increasing from
2988 in ovarian cancer to 3764 in colorectal cancer and 5988
in breast cancer. Moreover, the robustness of our conclusion
was also confirmed by down-sampling experiments using the
breast cancer data sets (see supplemental Text S2 and sup-
plemental Fig. S10).
The network topology may affect the priority scores of
genes in the network. Zhang et al. (44) tried to remove this
effect by assessing the statistical significance of the scores.
To evaluate whether considering network topology could im-
prove network-based function prediction, we combined two
statistic metrics, localP and edgeP, with the rank ratio metric
for assessing the significance of the priority scores (see sup-
plemental Text S2). On average, considering network topol-
ogy only increased the AUROCs less than 2% (supplemental
Fig. S11). Furthermore, results based on all three types of
AUROCs consistently suggest that protein networks sig-
nificantly outperformed mRNA networks in gene function pre-
diction.
In conclusion, our results demonstrate that proteome pro-
filing outperforms transcriptome profiling for coexpression
based gene function prediction. The GBA strategies devel-
oped in transcriptomic studies would be more effective when
applied to proteomic data. Gene function and disease studies
would benefit immensely from broad adoption of global pro-
teome profiling technologies.
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